The association between the gut microbiota metabolite trimethylamine N-oxide and heart failure
- PMID: 39391607
- PMCID: PMC11464299
- DOI: 10.3389/fmicb.2024.1440241
The association between the gut microbiota metabolite trimethylamine N-oxide and heart failure
Abstract
This systematic review explores the relationship between the gut microbiota metabolite trimethylamine N-oxide (TMAO) and heart failure (HF), given the significant impact of TMAO on cardiovascular health. A systematic search and meta-analysis of peer-reviewed studies published from 2013 to 2024 were conducted, focusing on adult patients with heart failure and healthy controls. The review found that elevated levels of TMAO are associated with atherosclerosis, endothelial dysfunction, and increased cardiovascular disease risk, all of which can exacerbate heart failure. The analysis also highlights that high TMAO levels are linked to reduced left ventricular ejection fraction (LVEF) and glomerular filtration rate (GFR), further supporting TMAO's role as a biomarker in heart failure assessment. The findings suggest that interventions targeting gut microbiota to reduce TMAO could potentially benefit patients with heart failure, although further research is needed to evaluate the effectiveness of such approaches.
Keywords: TMAO; chronic heart failure; gut microbiome; heart failure; metabolite.
Copyright © 2024 Jarmukhanov, Mukhanbetzhanov, Kozhakhmetov, Nurgaziyev, Sailybayeva, Bekbossynova and Kushugulova.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure.J Intern Med. 2015 Jun;277(6):717-26. doi: 10.1111/joim.12328. Epub 2014 Dec 1. J Intern Med. 2015. PMID: 25382824
-
Trimethylamine-N-Oxide (TMAO) as a Rising-Star Metabolite: Implications for Human Health.Metabolites. 2025 Mar 24;15(4):220. doi: 10.3390/metabo15040220. Metabolites. 2025. PMID: 40278349 Free PMC article. Review.
-
Choline Diet and Its Gut Microbe-Derived Metabolite, Trimethylamine N-Oxide, Exacerbate Pressure Overload-Induced Heart Failure.Circ Heart Fail. 2016 Jan;9(1):e002314. doi: 10.1161/CIRCHEARTFAILURE.115.002314. Epub 2015 Dec 23. Circ Heart Fail. 2016. PMID: 26699388 Free PMC article.
-
Trimethylamine N-Oxide and Risk of Cardiovascular Disease and Mortality.Curr Nutr Rep. 2018 Dec;7(4):207-213. doi: 10.1007/s13668-018-0252-z. Curr Nutr Rep. 2018. PMID: 30362023 Review.
-
Trimethylamine/Trimethylamine-N-Oxide as a Key Between Diet and Cardiovascular Diseases.Cardiovasc Toxicol. 2021 Aug;21(8):593-604. doi: 10.1007/s12012-021-09656-z. Epub 2021 May 18. Cardiovasc Toxicol. 2021. PMID: 34003426 Review.
Cited by
-
Precision nutrition across climates: decoding diet, tradition, and genomic adaptations from South Asia to the Arctic.Front Nutr. 2025 Aug 14;12:1638843. doi: 10.3389/fnut.2025.1638843. eCollection 2025. Front Nutr. 2025. PMID: 40896188 Free PMC article. Review.
-
An Exploration of the Relationship Between Gut Virome and Cardiovascular Disease: A Comprehensive Review.Rev Cardiovasc Med. 2025 Jun 24;26(6):36386. doi: 10.31083/RCM36386. eCollection 2025 Jun. Rev Cardiovasc Med. 2025. PMID: 40630433 Free PMC article. Review.
-
The Role of the Gut Microbiota in Heart Failure: Pathophysiological Insights and Future Perspectives.Medicina (Kaunas). 2025 Apr 14;61(4):720. doi: 10.3390/medicina61040720. Medicina (Kaunas). 2025. PMID: 40283011 Free PMC article. Review.
-
Gut Microbiota Metabolites and Chronic Diseases: Interactions, Mechanisms, and Therapeutic Strategies.Int J Mol Sci. 2025 Apr 16;26(8):3752. doi: 10.3390/ijms26083752. Int J Mol Sci. 2025. PMID: 40332366 Free PMC article. Review.
-
The Role of Gut Microbiota-Derived Trimethylamine N-Oxide in the Pathogenesis and Treatment of Mild Cognitive Impairment.Int J Mol Sci. 2025 Feb 6;26(3):1373. doi: 10.3390/ijms26031373. Int J Mol Sci. 2025. PMID: 39941141 Free PMC article. Review.
References
-
- Amrein M., Li X. S., Walter J., Wang Z., Zimmermann T., Strebel I., et al. . (2022). Gut microbiota-dependent metabolite trimethylamine N-oxide (TMAO) and cardiovascular risk in patients with suspected functionally relevant coronary artery disease (fCAD). Clin. Res. Cardiol. 111, 692–704. doi: 10.1007/s00392-022-01992-6, PMID: - DOI - PMC - PubMed
-
- Bartolomaeus H., Avery E. G., Bartolomaeus T. U. P., Kozhakhmetov S., Zhumadilov Z., Müller D. N., et al. . (2020). Blood pressure changes correlate with short-chain fatty acid production potential shifts under a Synbiotic intervention. Cardiovasc. Res. 116, 1252–1253. doi: 10.1093/cvr/cvaa083, PMID: - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous